Found: 7
Select item for more details and to access through your institution.
Mitogen‐activated protein kinase kinase kinase 1 facilitates the temozolomide resistance and migration of GBM via the MEK/ERK signalling.
- Published in:
- Journal of Cellular & Molecular Medicine, 2024, v. 28, n. 20, p. 1, doi. 10.1111/jcmm.70173
- By:
- Publication type:
- Article
MAPK-activated protein kinase 2 is associated with poor prognosis of glioma patients and immune inhibition in glioma.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1307992
- By:
- Publication type:
- Article
A novel mouse CD133 binding-peptide screened by phage display inhibits cancer cell motility in vitro.
- Published in:
- Clinical & Experimental Metastasis, 2012, v. 29, n. 3, p. 185, doi. 10.1007/s10585-011-9440-6
- By:
- Publication type:
- Article
MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 10, p. 11624, doi. 10.1002/cam4.5859
- By:
- Publication type:
- Article
MAPK Activated Protein Kinase 3 Is a Prognostic-Related Biomarker and Associated With Immune Infiltrates in Glioma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.793025
- By:
- Publication type:
- Article
Clinical value of CagA, c-Met, PI3K and Beclin-1 expressed in gastric cancer and their association with prognosis.
- Published in:
- Oncology Letters, 2018, v. 15, n. 1, p. 947, doi. 10.3892/ol.2017.7394
- By:
- Publication type:
- Article
PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway.
- Published in:
- Cancer Science, 2022, v. 113, n. 2, p. 500, doi. 10.1111/cas.15214
- By:
- Publication type:
- Article